Symbiotec Pharmalab Ltd
Held by 32 mutual fund schemes, ₹927.56Cr between them.
The largest single position is Motilal Oswal Small Cap Fund (Motilal Oswal), which holds 1.4% of its portfolio in Symbiotec Pharmalab Ltd — ₹112.72Cr, or 12.2% of all the mutual fund money in this stock.
The five largest holders account for 51% of it, across 32 schemes in total.
7 of the 32 largest holdings sit in sectoral/ thematic funds, the most of any category here.
SYMBIOTEC is under NSE’s short-term Additional Surveillance Measure (Stage I) — the exchange has flagged unusual price or volume activity, and trading in it carries extra margin.
Funds holding Symbiotec Pharmalab Ltd
32Largest rupee position first. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
| Fund | Category | Weight | Position | Fund size |
|---|---|---|---|---|
| Motilal Oswal Small Cap Fund | Small Cap Fund | 1.43% | ₹112.72Cr | ₹7,883Cr |
| ICICI Prudential Small Cap Fund | Small Cap Fund | 1.10% | ₹106.43Cr | ₹9,651Cr |
| Mirae Asset Aggressive Hybrid Fund | Aggressive Hybrid Fund | 1.05% | ₹99.56Cr | ₹9,512Cr |
| Mirae Asset Midcap Fund | Mid Cap Fund | 0.45% | ₹90.58Cr | ₹20,305Cr |
| Mirae Asset ELSS Tax Saver Fund | ELSS | 0.26% | ₹68.38Cr | ₹26,128Cr |
| Mirae Asset Multicap Fund | Multi Cap Fund | 1.20% | ₹66.20Cr | ₹5,502Cr |
| Mirae Asset Healthcare Fund | Sectoral/ Thematic | 1.66% | ₹57.37Cr | ₹3,458Cr |
| Mirae Asset Small Cap Fund | Small Cap Fund | 1.00% | ₹54.66Cr | ₹5,463Cr |
| HDFC Pharma and Healthcare Fund | Sectoral/ Thematic | 1.38% | ₹43.17Cr | ₹3,128Cr |
| Mahindra Manulife Small Cap Fund | Small Cap Fund | 0.61% | ₹32.04Cr | ₹5,252Cr |
| Mirae Asset Flexi Cap Fund | Flexi Cap Fund | 0.47% | ₹20.79Cr | ₹4,423Cr |
| Edelweiss Large Cap Fund | Large Cap Fund | 1.39% | ₹19.80Cr | ₹1,425Cr |
| Helios Small Cap Fund | Small Cap Fund | 1.00% | ₹16.07Cr | ₹1,607Cr |
| Baroda BNP Paribas Focused Fund | Focused Fund | 2.46% | ₹15.27Cr | ₹620.93Cr |
| Mirae Asset Multi Asset Allocation Fund | Multi Asset Allocation | 0.38% | ₹13.73Cr | ₹3,622Cr |
| ITI Flexi Cap Fund | Flexi Cap Fund | 0.74% | ₹11.29Cr | ₹1,526Cr |
| ITI Multi Cap Fund | Multi Cap Fund | 0.73% | ₹10.97Cr | ₹1,503Cr |
| Groww Multicap Fund | Multi Cap Fund | 0.88% | ₹10.82Cr | ₹1,233Cr |
| Tata Flexi Cap Fund | Flexi Cap Fund | 0.28% | ₹10.24Cr | ₹3,656Cr |
| Mirae Asset Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.39% | ₹8.37Cr | ₹2,157Cr |
| Baroda BNP Paribas Health and Wellness Fund | Sectoral/ Thematic | 1.59% | ₹8.11Cr | ₹509.83Cr |
| TRUSTMF Multi Cap Fund | Multi Cap Fund | 1.01% | ₹7.64Cr | ₹756.77Cr |
| Tata India Pharma & Healthcare Fund | Sectoral/ Thematic | 0.48% | ₹7.37Cr | ₹1,534Cr |
| Mirae Asset Equity Savings Fund | Equity Savings | 0.32% | ₹6.51Cr | ₹2,018Cr |
| Groww Small Cap Fund | Small Cap Fund | 0.91% | ₹6.28Cr | ₹687.95Cr |
| Baroda BNP Paribas Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.12% | ₹6.24Cr | ₹5,204Cr |
| HDFC MNC Fund | Sectoral/ Thematic | 1.11% | ₹6.13Cr | ₹552.24Cr |
| Edelweiss Recently Listed IPO Fund | Sectoral/ Thematic | 0.41% | ₹4.84Cr | ₹1,181Cr |
| TRUSTMF Large & Midcap Fund | Large & Mid Cap Fund | 0.90% | ₹2.43Cr | ₹269.86Cr |
| Edelweiss Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.05% | ₹1.96Cr | ₹3,918Cr |
| PGIM India Healthcare Fund | Sectoral/ Thematic | 1.07% | ₹1.27Cr | ₹118.25Cr |
| Baroda BNP Paribas Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.22% | ₹32.88L | ₹149.44Cr |
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Funds buying and selling Symbiotec Pharmalab Ltd
In their latest monthly disclosure, 5 funds bought and 11 sold, judged by share count.
| Fund | Move | Weight | Value |
|---|---|---|---|
| Mirae Asset Midcap Fund | New | — → 0.45% | ₹87.17Cr |
| Mirae Asset Multicap Fund | New | — → 1.20% | ₹64.72Cr |
| Mirae Asset ELSS Tax Saver Fund | New | — → 0.26% | ₹64.44Cr |
| Mirae Asset Small Cap Fund | Added | 0.00% → 1.00% | ₹57.95Cr |
| Mirae Asset Flexi Cap Fund | Cut | 0.67% → 0.47% | -₹10.27Cr |
| WhiteOak Capital Multi Asset Allocation Fund | Exited | 0.07% → — | -₹6.02Cr |
| ICICI Prudential Innovation Fund | Exited | 0.08% → — | -₹5.88Cr |
| ICICI Prudential Exports & Services Fund | Exited | 0.24% → — | -₹3.53Cr |
| TRUSTMF Large & Midcap Fund | Cut | 1.42% → 0.90% | -₹2.19Cr |
| ITI Flexi Cap Fund | Added | 0.65% → 0.74% | ₹1.09Cr |
| Baroda BNP Paribas Services Fund | Exited | 0.11% → — | -₹61.38L |
| HDFC MNC Fund | Cut | 1.11% → 1.11% | -₹56.08L |
| WhiteOak Capital Balanced Advantage Fund | Exited | 0.02% → — | -₹47.39L |
| Baroda BNP Paribas Children's Fund | Exited | 0.04% → — | -₹4.92L |
| Tata Flexi Cap Fund | Cut | 0.52% → 0.28% | — |
| Tata India Pharma & Healthcare Fund | Cut | 0.87% → 0.48% | — |
Frequently asked questions
Which mutual fund holds the most Symbiotec Pharmalab Ltd?
By rupee value, Motilal Oswal Small Cap Fund from Motilal Oswal — ₹112.72Cr, at 1.4% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
Which fund has the highest weight in Symbiotec Pharmalab Ltd?
Baroda BNP Paribas Focused Fund carries the largest weight at 2.5% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.
How many mutual funds hold Symbiotec Pharmalab Ltd?
32 schemes, holding ₹927.56Cr between them across the 32 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding Symbiotec Pharmalab Ltd make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.